# COVID19_IFR
MIDAS Consensus Range for COVID-19 Infection Fatality Rates

Ongoing community-based review of IFR estimates for COVID-19

## Endorsed IFR Estimates (All ages)
|Population | Country | Time Period | IFR Point Estimate | IFR Uncertainty range | Study |
|---|---|---|---|---|---|
|test | US | 2020-01-01 - 2020-05-09 | 0.01 | 0.00-0.02 | Ref |

## Endorsed IFR Estimates (Age specific)
|Population | Age Group| Country | Time Period | IFR Point Estimate | IFR Uncertainty range | Study |
|---|---|---|---|---|---|---|
|test |0-5 |US | 2020-01-01 - 2020-05-09 | 0.01 | 0.00-0.02 | Ref |


## Study Review Status
Each entry links to a study details page for review.

| Study | Title |Description | Study Population | Age Group | Country | Time Period | Review Status |
|---|---|---|---|---|---|---|---|
| [Bendavid et al., MedRXiv Apr 30, 2020](https://www.medrxiv.org/content/10.1101/2020.04.14.20062463v2) | COVID-19 Antibody Seroprevalence in Santa Clara County, California | IFR estimated from infections detected through sero-survey in Santa Clara County, CA, and deaths reported by public health surveillance | General population | All ages | United States | 2020-04-03 - 2020-04-22 | None completed |
| [Russell et al., Eurosurveillance Mar 26, 2020](https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.12.2000256#html_fulltext) |Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020 |---|---|---|---|---|Preparation pending|
|[Salje et al., Science Jul 20, 2020](https://science.sciencemag.org/content/369/6500/208)|Estimating the burden of SARS-CoV-2 in France|---|---|---|---|---|Preparation pending|
|[Roques et al., Biology May 8, 2020](https://www.mdpi.com/2079-7737/9/5/97)|Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France|---|---|---|---|---|Preparation pending|
|[Ferguson et al., Imperial College Report 9 March 16, 2020](https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-9-impact-of-npis-on-covid-19/)|Report 9 - Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand|---|---|---|---|---|Preparation pending|
|[Basset, MedRXiv, Apr 27, 2020](https://www.medrxiv.org/content/10.1101/2020.04.22.20076026v1)|Strict Lower Bound on the COVID-19 Fatality Rate in Overwhelmed Healthcare Systems|---|---|---|---|---|Preparation pending|
|[Streeck et al., MedRXiv, June 2, 2020](https://www.medrxiv.org/content/10.1101/2020.05.04.20090076v2)|Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event|---|---|---|---|---|Preparation pending|




Streeck et al.
Verity et al.
Jung et al.
Stringhini et al.
Tian et al.
Grewelle et al.
Villa et al.
Nishiura et al.
Rinaldi et al.
Shakiba et al.
Modi et al.
Snoeck et al.
CEBM
Wu et al.
Indiana State Government
Government of Slovenia
Government of the Czech Republic *no link available online
Folkhälsomyndigheten *Not in english
ESTUDIO NACIONAL DE SERO-EPIDEMIOLOGÍA DE LA INFECCIÓN POR SARS-COV-2 EN
ESPAÑA.
*No link
